Hyun Woong Lee
Overview
Explore the profile of Hyun Woong Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yim H, Seo Y, Kim J, Kim W, Jung Y, Jang J, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39828249
Background/aims: Besifovir (BSV) showed comparable antiviral activity superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy...
2.
Hur M, Yip T, Kim S, Lee H, Lee H, Lee H, et al.
J Hepatol
. 2024 Sep;
82(2):235-244.
PMID: 39218223
Background & Aims: The risk of hepatocellular carcinoma (HCC) and hepatic decompensation persists after hepatitis B surface antigen (HBsAg) seroclearance. This study aimed to develop and validate a machine learning...
3.
Yoo S, Park J, Lee H, Lee H, Lee J
Ann Acad Med Singap
. 2024 Jun;
52(11):570-579.
PMID: 38920146
Introduction: Non-alcoholic fatty liver disease (NAFLD) is known to be associated with metabolic syndrome of which diabetes is an important component. Although diabetes is a known risk factor for dementia,...
4.
Yoo S, Nahm J, Lee W, Lee H, Chang H, Lee J
Mol Med
. 2023 Nov;
29(1):156.
PMID: 37946098
Background: Krüppel-like factor 10 (KLF10) is involved in a positive feedback loop that regulates transforming growth factor β (TGFβ) signaling, and TGFβ plays an important role in the pathogenesis of...
5.
Kim E, Lee H, Kim S, Yoon E, Jang E, Chang J, et al.
Aliment Pharmacol Ther
. 2023 Sep;
58(11-12):1185-1193.
PMID: 37694558
Background: As tenofovir disoproxil fumarate (TDF) requires long-term use, a reduction in bone density should be considered a possibility when treating patients with chronic hepatitis B (CHB) with aging and...
6.
Kim I, Yoo S, Lee J, Lee K, Lee H, Lim J
J Liver Cancer
. 2023 Jun;
22(1):84-90.
PMID: 37383537
There are various methods for treating advanced hepatocellular carcinoma with portal vein invasion, such as systemic chemotherapy, transarterial chemoembolization, transarterial radioembolization, and concurrent chemoradiotherapy. These methods have similar clinical efficacy...
7.
Chang Y, Jeong S, Jang J, Eun H, Lee Y, Song D, et al.
J Liver Cancer
. 2023 Jun;
22(2):167-177.
PMID: 37383408
Background/aim: New biomarkers are urgently needed to aid in the diagnosis of early stage hepatocellular carcinoma (HCC). We performed a meta-analysis on the diagnostic utility of circulating tumor DNA (ctDNA)...
8.
Kim J, Hur M, Kim S, Kim J, Sinn D, Lee H, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296898
Tenofovir disoproxil fumarate (TDF) is reportedly superior or at least comparable to entecavir (ETV) in preventing hepatocellular carcinoma (HCC) among chronic hepatitis B (CHB) patients; however, it remains controversial. This...
9.
Yoo S, Kim M, Kim S, Lee J, Lee K, Lee H, et al.
BMC Gastroenterol
. 2023 Apr;
23(1):116.
PMID: 37041473
Background: Some studies have analyzed the frequency of HCV RNA testing and actual treatment among anti-HCV positive patients in Korea, which has a low prevalence of HCV infection. This study...
10.
Lee J, Chang J, Jin Y, Lee J, Kim J, Sinn D, et al.
Eur J Gastroenterol Hepatol
. 2023 Feb;
35(4):431-439.
PMID: 36728881
Background And Aims: This study aimed to compare the long-term cumulative recurrence rates of hepatocellular carcinoma (HCC) and prognosis after curative resection for HCC in noncirrhotic patients with nonalcoholic fatty...